Monthly roundupPeriod scanned: 29 August – 28 September 20264 min listen
Preparedness commitments are becoming operational tests, but financing and oversight details remain open.
Audio briefing
4 min
|
Appendix: all 81 sources Iris scanned
Pandemic preparedness · 17
Pathogen surveillance and early warning · 16
Biosecurity policy and governance · 13
Medical countermeasures · 12
AI and biosecurity · 10
| AI-enabled biological design - European Parliament — europarl.europa.eu · 2026-09-23Official |
| At the frontier of biosecurity, risks and resilience are bot… — weforum.org · 2026-09-22News |
| Artificial Intelligence and Biosecurity Issues — congress.gov · 2026-09-15Official |
| People Are Trying to Misuse AI. That's Exactly Why Safeguard… — nti.org · 2026-09-11News |
| Appendix D — Further Reading and Resources — biosecurityhandbook.com · 2026-09-09News |
| EU AI Act for Biotech and Pharma (2026) | Confir — confir.eu · 2026-09-09News |
| Priorities for the UK Government on frontier AI risk and ... — longtermresilience.org · 2026-09-09News |
| China launches groundbreaking rules to govern frontier biome… — cell.com · 2026-09-08Research |
| New AI BioDesign accelerator combines experimental biology a… — freep.com · 2026-09-03News |
| The Proposed EU Biotech Act: New Biosecurity Rules for Artif… — insideeulifesciences.com · 2026-09-02News |
Biosafety incidents and oversight · 9
| Policy changes for life sciences research | UW Environmental… — ehs.washington.edu · 2026-09-25Research |
| Biosafety and Biosecurity Oversight Should Be a Visible ... — journals.sagepub.com · 2026-09-20News |
| Four Lab Safety Failures Found After Fatal Hydrofluoric Acid… — labmanager.com · 2026-09-17News |
| Federal Register :: Draft NIH Biosafety Policy… — federalregister.gov · 2026-09-12Official |
| Federal Register/Vol. 91, No. 176/Monday, September 14, ... — govinfo.gov · 2026-09-12Official |
| Request for Information; Clinical Laboratory Improvement ... — cap.org · 2026-09-09News |
| A Proposed Biosafety Rewrite Could Reshape Oversight ... — globalbiodefense.com · 2026-09-02News |
| IBC Policies | Institutional Compliance Committees — depts.ttu.edu · 2026-09-01Research |
| Biosafety and Biosecurity Research Topics — a-z-topics.com · 2026-08-30News |
Nucleic acid synthesis screening · 8
| Parliament study calls for mandatory DNA-order screening as … — 2eu.brussels · 2026-09-25News |
| Execution-aware agent harness for accessible and ... — biorxiv.org · 2026-09-25Research |
| AI-enabled biological design - European Parliament — europarl.europa.eu · 2026-09-23Official |
| European Biotech Act would require controls on synthetic DNA… — 2eu.brussels · 2026-09-16News |
| Combating new bioweapon risks: A Q&A with Dr Miranda ... — sipri.org · 2026-09-16News |
| H. Rept. 119-751 - NUCLEIC ACID STANDARDS FOR ... — congress.gov · 2026-09-15Official |
| US Has No DNA Screening Rule Before China Talks — otontechnology.com · 2026-09-08News |
| The Proposed EU Biotech Act: New Biosecurity Rules for Artif… — insideeulifesciences.com · 2026-09-02News |
Low signal — scanned and set aside · 3
| Digital Biology Market Size, Share and Analysis, 2026-2033 — coherentmarketinsights.com · 2026-09-25Low signal |
| Vaccines Market Size, Share, Growth, Analysis, Report, 2034 — straitsresearch.com · 2026-09-11Low signal |
| Recombinant Protein Market Size, Share, Forecast, 2034 — fortunebusinessinsights.com · 2026-08-31Low signal |
Tell Iris what to cover more, less, or differently. It shapes your next briefing.
This briefing was generated by Iris Briefings.
Iris uses artificial intelligence to synthesise recent developments in your field. It can make mistakes, so please verify anything critical against the linked primary sources before acting on it. Thank you for supporting Iris.
Want this for your field?
Iris builds a briefing agent around your own profile: your field, your focus areas, your context. Delivered on your schedule.
Iris is a tool that uses AI to find publicly available information and extract the insights that matter for you. Iris Briefings have taken precautions to ensure our systems are robust but these are not infallible. Nothing in your briefings should be taken for medical, legal or professional advice and Iris cannot take responsibility for your decisions. We encourage you to do your own due diligence on the primary sources that Iris references for critical decisions.